Healthy Skepticism Library
Items published during the years 1990 to 1999
There are 2362 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.
Page 20 of 24 pages ‹ First < 18 19 20 21 22 > Last ›
HSL4296
Lexchin J.
Drug promotion: two views. Canada
INRUD News 1991 Dec; 2:(2):3
HSL4297
Suryawati S, Santoso B.
Drug promotion: two views. Indonesia
INRUD News 1991 Dec; 2:(2):3
HSL9447
Wechsler J.
High cost of prescription drugs
Pharmaceutical Executive 1991 Dec; 11:12, 16-17
HSL4293
USA: Crackdown on misleading drug promotion
Lancet 1991 Nov 30; 338:1384
HSL9446
Gannon K.
Companion selling: high road to success
Drug Topics 1991 Nov 11; 135:42, 44, 47-48
HSL4213
Nixon AJ.
Stress and the ethical physician.
CMAJ 1991 Nov 1; 145:(9):1081
HSL9433
Moss F.
Advertising and pharmacy: European developments
Pharmaceutisch Weekblad 1991 Nov 1; 126:1100-1102
HSL4291
MaLAM Letter follow up—Wyeth withdraw Polymagma worldwide
MaLAM Newsletter 1991 Nov
HSL4292
Re: the promotion of iodoquinol
1991 Nov
HSL9424
Cavara C.
Innovative products in the pharmaceutical field: Part 3
Bollettino Chimico Farmaceutico 1991 Nov; 130:409-421
HSL9437
Cooper P.
Collection and delivery
Irish Pharmacy Journal 1991 Nov; 69:398-399
HSL4244
Woollard RF.
Snake oil and Caesar salad: the ethics of physician and pharmaceutical relationships.
CMAJ 1991 Oct 15; 145:(8):931-3
HSL9451
Bruinsma M, Dekker F.
Influencing the general practitioner by drug advertising
Pharmaceutisch Weekblad 1991 Oct 11; 126:1030-1035
HSL4194
Jelley M, Owen J.
Portrayal of women in advertisements.
Br J Psychiatry 1991 Oct; 159:586:
HSL4212
Murdoch LA, Lum L.
Timeliness of receipt of manufacturers' new product information.
Can J Hosp Pharm 1991 Oct; 44:(5):235-8
HSL4290
Re: the promotion of Festal
1991 Oct
HSL9452
Gore MJ.
Cost, safety, & efficacy: defining the pharmacist's role in drug-product selection
Consultant Pharmacist 1991 Oct; 6:771-775, 779, 781-784, 789
HSL9455
Top ten causes of medication errors
Hospital Pharmacy 1991 Oct; 26:907-908
HSL16720
Wolfe SM.
Medical ethics: a broader definition.
Mt Sinai J Med 1991 Oct; 58:(5):455-61
http://www.ncbi.nlm.nih.gov/pubmed/1753986
HSL4210
Miller JP.
Use of cost-benefit analysis in promotional material.
Lancet 1991 Sep 28; 338:(8770):823-4
HSL19781
Garattini S
Italy: An end to the fun and games?
The Lancet 1991 Sep 21; 338:(8769):749 - 750
http://www.thelancetnorway.com/journals/lancet/article/PII0140-6736%2891%2991460-C/fulltext
HSL4242
Williams JR, Hensel PJ.
Changes in physicians' sources of pharmaceutical information: a review and analysis.
J Health Care Mark 1991 Sep; 11:(3):46-60
HSL9449
Oslund CA.
Pharmaceutical marketplace
Minnesota Pharmacist 1991 Sep; 45:13-16
HSL9450
Managed health care: blessing and a burden
Pharmacy Times 1991 Sep; 57:86-88
HSL9454
Hamacher DP.
Cold/allergy/sinus remedies
National Association of Retail Druggists Journal 1991 Sep; 113:71-72
HSL4287
Farewell to promoting goodbuys.
Lancet 1991 Aug 17; 338:(8764):416-7
HSL20042
Antimotion promotion commotion
Lancet 1991 Aug 3; 338:(8762):307
http://www.lancet.com/journals/lancet/article/PII0140-6736%2891%2990444-T/fulltext
HSL1871
Busby J.
Ties that bind? The web of CME and medical industry profit
Tex Med. 1991 Aug; 87:(8):38-46
HSL4245
Zellmer WA.
Pharmaceutical promotion and pharmacist probity.
Am J Hosp Pharm 1991 Aug; 48:(8):1693
HSL4284
MaLAM Letter follow up—Hoechst pentoxifylline
MaLAM Newsletter 1991 Aug
HSL4285
MaLAM Letter follow up—Searle diiodohydroxyquinoline
MaLAM Newsletter 1991 Aug
HSL4286
Re: the promotion of Carbazochrome
1991 Aug
HSL9453
Stephenson J.
Who gains, who loses from a European formulary?
Pharmaceutical Executive 1991 Aug; 11:26, 28-29
HSL9456
Hemming MP.
The nontraditional use of commercial advertising in prescriber education.
Hosp Pharm 1991 Aug; 26:(8):693,
HSL20543
Kelly S
European drug regulation
The Lancet 1991 July 27; 338:(8761):257
http://www.lancet.com/journals/lancet/article/PII0140-6736%2891%2990399-A/fulltext
HSL20540
The FDA's Ambitious New Chief - the Schwartz commentary
Scrip 1991 July 19; 1635:16-18
HSL4197
Kessler DA.
Drug promotion and scientific exchange. The role of the clinical investigator
N Engl J Med. 1991 Jul 18;325(3):201-3 1991 Jul 18; 325:(3):201-3
HSL4228
Shimm DS, Spece RG Jr.
Industry reimbursement for entering patients into clinical trials: legal and ethical issues.
Ann Intern Med 1991 Jul 15; 115:(2):148-51
HSL4283
Rennie D, Flanagin A, Glass RM.
Conflicts of interest in the publication of science
JAMA 1991 Jul 10; 266:(2):266-267
HSL4275
Corpus JT.
Gifts to physicians from industry [5th of 5 letters]
JAMA 1991 Jul 3; 266:(1):62-63
HSL4276
Goldstein AO.
Gifts to physicians from industry [1st of 5 letters]
JAMA 1991 Jul 3; 266:(1):61
HSL4277
Leblond RF.
Gifts to physicians from industry [2nd of 5 letters]
JAMA 1991 Jul 3; 266:(1):61-62
HSL4278
Leung AK, Robson WM.
Gifts to physicians from industry [3rd of 5 letters]
JAMA 1991 Jul 3; 266:(1):62
HSL4279
McMurray RJ, Orentlicher D.
Gifts to physicians from industry [1st of 2 replies]
JAMA 1991 Jul 3; 266:(1):63
HSL4281
Randall T.
Gifts to physicians from industry [2nd of 2 replies]
JAMA 1991 Jul 3; 266:(1):63
HSL4282
Sanders JH.
Gifts to physicians from industry [4th of 5 letters]
JAMA 1991 Jul 3; 266:(1):62
HSL4236
Terry PB.
Pulmonary physicians, principles, and pharmaceuticals.
Chest 1991 Jul; 100:(1):223-6
HSL4274
Feisullin S, Sause RB.
Update on direct-to-consumer advertising of prescription drugs.
Am Pharm 1991 Jul; NS31:(7):47-52
HSL9458
American Academy of Pediatrics Committee on Drugs: Prescription drug advertising direct to the consumer.
Pediatrics. 1991 Jul; 88:(1):174-5
HSL9472
Drea EJ, Groesch AA, Hester FG, Mutnick AH.
Clinical strategies in drug therapy selection: an application of "counter-detailing".
Top Hosp Pharm Manage 1991 Jul; 11:(2):70-8
HSL20538
The FDA comes to life
The Lancet 1991 Jun 22; 337:1533
HSL20490
Hailstone B
Doctors 'misled' by advertising
The Advertiser 1991 Jun 1810
HSL9460
Conlan MF.
After the storm: has the scandal shaken your confidence?
Drug Topics 1991 Jun 17; 135:40-42, 44
HSL9462
Conlan MF.
FDA eyes product ID code for all Rxs and OTCs
Drug Topics 1991 Jun 17; 135:48
HSL4266
MaLAM Letter follow up—Can we tolerate Rhone Poulenc Rorer’s claims?
MaLAM Newsletter 1991 Jun
HSL4267
Re: the promotion of spiramycin
1991 Jun
HSL4268
Summary of correspondence July ’89—December ’90
MaLAM Newsletter 1991 Jun
HSL4269
Huston P.
Surviving in a get-tough-on promotion climate
Medical Marketing & Media 1991 Jun; 26:(6):40-46, 48, 50-51
HSL4271
Sweeney HA.
Nothing has changed in 25 years
Medical Marketing & Media 1991 Jun; 26:(6):42
HSL4272
Wolfe SM.
Promotional practices in the pharmaceutical industry
HAI News 1991 Jun; (59):1-2, 10-11
HSL4273
Re: the promotion of Polymagma
1991 Jun
HSL9469
Schwartz H.
Mail-order pharmacy squeezes drug prices
Pharmaceutical Executive 1991 Jun; 11:20, 24, 27
HSL9471
Schwartz RM, Rifkin SM.
No more paper tiger
American Druggist 1991 Jun; 203:26-27, 30, 32, 34
HSL9477
1990 Rise in prescription drug prices averages nearly 8%
American Journal of Hospital Pharmacy 1991 Jun; 48:1122
HSL20535
Aders HP
Legal Liabilty and Drug Prescribing
Current Therapeutics 1991 Jun; 32:(6):17-21
HSL4190
Hillman AL, Eisenberg JM, Pauly MV, Bloom BS, Glick H, Kinosian B, Schwartz JS.
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.
N Engl J Med 1991 May 9; 324:(19):1362-5
HSL4185
Goldstein JH.
Of mugs and marketing.
JAMA 1991 May 8; 265:(18):2391-2
HSL4219
Rennie D.
Editors and advertisements? What responsibility do editors have for the advertisements in their journals
JAMA. 1991 May 08; 265:(18):2394-6
HSL4264
Randall T.
AMA, pharmaceutical association form 'solid front' on gift-giving guidelines.
JAMA 1991 May 8; 265:(18):2304-5
HSL4265
Randall T.
Not all drug firms subject to gifts guidelines, but, for physicians, their gifts are still taboo.
JAMA 1991 May 8; 265:(18):2305
HSL20515
Kahtan S, Charny M, Johnston JD, Breimer LH
Publication bias
The Lancet 1991 May 4; 337:(8749):1102
http://www.lancet.com/journals/lancet/article/PII0140-6736%2891%2991754-I/fulltext
HSL5424
Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J.
Opinion leaders vs audit and feedback to implement practice guidelines Delivery after previous cesarean section.
JAMA 1991 May 1; 265:(17):2202-7
HSL4263
Industry promotions: institutionalized deception
Drug Monitor 1991 May; 6:(5):49-51
HSL9457
Sesti LM, Miles WA.
Concerning the case of: United States v American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No G75-558 CA5, WD Michigan
Journal Michigan Pharmacist 1991 May; 29:182-183
HSL9459
Dicello CA.
What pharmacy needs from industry to optimize pharmaceutical care
Pennsylvania Pharmacist 1991 May; 72:17-18
HSL9474
Summers KH.
Managed health's impact on pharmacy practice
US-Pharmacist 1991 May; 16:H16, H22-H24, H36
HSL9475
Davis JL, Madhavan S.
Should prescription drugs be advertised to consumers?
American Druggist 1991 May; 203:82, 84-85
HSL9476
Schwartz RM.
ASCP to Pryor: where are our discounts?
American Druggist 1991 May; 203:24, 26
HSL4180
Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR.
Publication bias in clinical research.
Lancet 1991 Apr 13; 337:(8746):867-72
HSL4262
The world according to Ernest: the ethics of marketing drugs
The Economist 1991 Apr 668
HSL4203
Lexchin J.
PAAB: a lesson in self-government.
CMAJ 1991 Apr 1; 144:(7):844-5
HSL4258
Re: the promotion of di-iodohydroxyquinolone
1991 Apr
HSL4259
Credibility and the marketing mix
1991 Apr
HSL4260
Griffin JP.
Who will fund postgraduate education after 1992?
J R Coll Physicians Lond 1991 Apr; 25:(2):128
http://www.ncbi.nlm.nih.gov/pubmed/2066922
HSL4261
Everett SE.
Lay audience response to prescription drug advertising
Journal of Advertising Research 1991 Apr-May; 31:43-49
HSL9467
Kirkpatrick MA.
Planning and executing a brown bag day
Pharmacy Times 1991 Apr; 57:90, 93, 96, 98
HSL9468
Mail order prescription drug industry origins and growth
Pharmacy Business 1991 Apr; 2:12, 21
HSL20167
Carlini EA
Brazil: Pharmaceutical industry fears informed criticism
The Lancet 1991 Mar 23; 337:724
http://www.lancet.com/journals/lancet/article/PII0140-6736%2891%2990295-Z/fulltext
HSL4257
Randall T.
New guidelines examine drug firm, CME relations.
JAMA 1991 Mar 20; 265:(11):1354
HSL4256
Purvis A.
Cheaper can be better
Time 1991 Mar 1835
HSL4280
Randall T.
FDA scrutinizes 'off-label' promotions
JAMA 1991 Mar 7; 266:(1):11
HSL4226
Scarpinato L.
Pharmaceutical representatives.
J Gen Intern Med 1991 Mar-Apr; 6:(2):181
HSL4255
Re: the promotion of arginine asparate
1991 Mar
HSL9436
Joughin J.
Animal pharm
Pharmaceutical and Cosmetic Review 1991 Mar-Apr; 18:28, 30
HSL9465
Blyth JS.
Pharmaceutical marketing in a new package
Pharmaceutical Executive 1991 Mar; 11:86, 88
HSL9466
Huntsinger L.
How Medicaid's new drug legislation will affect Oregon's drug use review and prudent purchasing programs Part 2
Oregon Pharmacist 1991 Mar; 39:8
HSL4209
Mick T.
Pharmaceutical funding and medical students.
JAMA 1991 Feb 6; 265:(5):659,
HSL4254
Kleinerman MJ.
The hand that feeds.
JAMA 1991 Feb 6; 265:(5):658,
HSL20503
French promotional tax survives appeal
Scrip 1991 Feb 62
HSL1774
Goodfriend TL.
Using pharmaceutical advertising in medical education.
Acad Med 1991 Feb; 66:(2):122
Page 20 of 24 pages ‹ First < 18 19 20 21 22 > Last ›
